The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curti, A.
Right arrow Articles by Lemoli, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curti, A.
Right arrow Articles by Lemoli, R. M.
The Journal of Immunology, 2001, 166: 848-854.
Copyright © 2001 by The American Association of Immunologists

Stem Cell Factor and FLT3-Ligand Are Strictly Required to Sustain the Long-Term Expansion of Primitive CD34+DR- Dendritic Cell Precursors

Antonio Curti1, Miriam Fogli, Marina Ratta, Sante Tura and Roberto M. Lemoli2

Institute of Hematology and Medical Oncology "Ludovico e Ariosto Seràgnoli," University of Bologna, Bologna, Italy

We studied cytokine-driven differentiation of primitive human CD34+HLA-DR- cells to myeloid dendritic cells (DC). Hemopoietic cells were grown in long-term cultures in the presence of various combinations of early acting cytokines such as FLT3-ligand (FLT3-L) and stem cell factor (SCF) and the differentiating growth factors GM-CSF and TNF-{alpha}. Two weeks of incubation with GM-CSF and TNF-{alpha} generated fully functional DC. However, clonogenic assays demonstrated that CFU-DC did not survive beyond 1 wk in liquid culture regardless of whether FLT3-L and/or SCF were added. FLT3-L or SCF alone did not support DC maturation. However, the combination of the two early acting cytokines allowed a 100-fold expansion of CFU-DC for >1 month. Phenotypic analysis demonstrated the differentiation of CD34+DR- cells into CD34-CD33+DR+CD14+ cells, which were intermediate progenitors capable of differentiating into functionally active DC upon further incubation with GM-CSF and TNF-{alpha}. As expected, GM-CSF and TNF-{alpha} generated DC from committed CD34+DR+ cells. However, only SCF, with or without FLT3-L, induced the expansion of DC precursors for >4 wk, as documented by secondary clonogenic assays. This demonstrates that although GM-CSF and TNF-{alpha} do not require additional cytokines to generate DC from primitive human CD34+DR- progenitor cells, they do force terminal differentiation of DC precursors. Conversely, FLT3-L and SCF do not directly affect DC differentiation, but instead sustain the long-term expansion of CFU-DC, which can be induced to produce mature DC by GM-CSF and TNF-{alpha}.




This article has been cited by other articles:


Home page
Int ImmunolHome page
B. B. Ganesh, D. M. Cheatem, J. R. Sheng, C. Vasu, and B. S. Prabhakar
GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis
Int. Immunol., March 1, 2009; 21(3): 269 - 282.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. van Cruijsen, A. A.M. van der Veldt, L. Vroling, D. Oosterhoff, H. J. Broxterman, R. J. Scheper, G. Giaccone, J. B.A.G. Haanen, A. J.M. van den Eertwegh, E. Boven, et al.
Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
Clin. Cancer Res., September 15, 2008; 14(18): 5884 - 5892.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. I. Slukvin, M. A. Vodyanik, J. A. Thomson, M. E. Gumenyuk, and K.-D. Choi
Directed Differentiation of Human Embryonic Stem Cells into Functional Dendritic Cells through the Myeloid Pathway.
J. Immunol., March 1, 2006; 176(5): 2924 - 2932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Vermaelen and R. Pauwels
Pulmonary Dendritic Cells
Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 530 - 551.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. Encabo, P. Solves, E. Mateu, P. Sepulveda, F. Carbonell-Uberos, and M. D. Minana
Selective Generation of Different Dendritic Cell Precursors from CD34+ Cells by Interleukin-6 and Interleukin-3
Stem Cells, September 1, 2004; 22(5): 725 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Vasu, R.-N. E. Dogan, M. J. Holterman, and B. S. Prabhakar
Selective Induction of Dendritic Cells Using Granulocyte Macrophage-Colony Stimulating Factor, But Not fms-Like Tyrosine Kinase Receptor 3-Ligand, Activates Thyroglobulin-Specific CD4+/CD25+ T Cells and Suppresses Experimental Autoimmune Thyroiditis
J. Immunol., June 1, 2003; 170(11): 5511 - 5522.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. G. Gilliland and J. D. Griffin
The roles of FLT3 in hematopoiesis and leukemia
Blood, August 13, 2002; 100(5): 1532 - 1542.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. J. Masterson, C. C. Sombroek, T. D. de Gruijl, Y. M. F. Graus, H. J. J. van der Vliet, S. M. Lougheed, A. J. M. van den Eertwegh, H. M. Pinedo, and R. J. Scheper
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors
Blood, June 28, 2002; 100(2): 701 - 703.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Ratta, F. Fagnoni, A. Curti, R. Vescovini, P. Sansoni, B. Oliviero, M. Fogli, E. Ferri, G. R. Della Cuna, S. Tura, et al.
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
Blood, June 17, 2002; 100(1): 230 - 237.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. O. Muench and A. Barcena
Broad Distribution of Colony-Forming Cells with Erythroid, Myeloid, Dendritic Cell, and NK Cell Potential Among CD34++ Fetal Liver Cells
J. Immunol., November 1, 2001; 167(9): 4902 - 4909.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.